Coloured Ties Capital Inc. (TIE.V)
CAD 0.2
(14.29%)
CAD 0.2
(14.29%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -2.34 Million CAD | -171.93% |
| 2021 | 3.25 Million CAD | 0.0% |
| 2019 | -276 Thousand CAD | -100.75% |
| 2018 | 36.59 Million CAD | 1163.53% |
| 2017 | -3.44 Million CAD | 11.41% |
| 2016 | -3.88 Million CAD | -134.5% |
| 2015 | 11.25 Million CAD | 330.76% |
| 2014 | -4.87 Million CAD | -111.22% |
| 2013 | 43.47 Million CAD | 98.9% |
| 2012 | 21.86 Million CAD | 325.77% |
| 2011 | -9.68 Million CAD | -52.15% |
| 2010 | -6.36 Million CAD | -248.72% |
| 2009 | 4.27 Million CAD | 210.26% |
| 2008 | -3.88 Million CAD | -6037.61% |
| 2007 | -63.23 Thousand CAD | -709.73% |
| 2006 | -7809.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | -15.94 Million CAD | -625.52% |
| 2023 Q1 | -2.19 Million CAD | 42.19% |
| 2023 Q3 | -8.31 Million CAD | 47.83% |
| 2022 Q3 | 1.88 Million CAD | 405.02% |
| 2022 Q4 | -3.8 Million CAD | -302.02% |
| 2022 FY | - CAD | -171.93% |
| 2022 Q1 | 217 Thousand CAD | -92.3% |
| 2022 Q2 | -617 Thousand CAD | -384.33% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q2 | -628 Thousand CAD | -141.05% |
| 2021 Q4 | 2.82 Million CAD | 487.36% |
| 2021 Q3 | -728 Thousand CAD | -15.92% |
| 2021 Q1 | 1.53 Million CAD | 0.0% |
| 2020 Q2 | -2.65 Million CAD | -268.16% |
| 2020 Q3 | -326 Thousand CAD | 87.73% |
| 2020 Q1 | 1.58 Million CAD | 277.99% |
| 2019 Q2 | -1.11 Million CAD | -102.9% |
| 2019 Q4 | 418 Thousand CAD | 136.16% |
| 2019 FY | - CAD | -100.75% |
| 2019 Q1 | 38.59 Million CAD | 3089.42% |
| 2019 Q3 | -1.15 Million CAD | -3.4% |
| 2018 Q4 | 1.21 Million CAD | 172.28% |
| 2018 FY | - CAD | 1163.53% |
| 2018 Q3 | -1.67 Million CAD | -9.27% |
| 2018 Q1 | -557 Thousand CAD | 32.07% |
| 2018 Q2 | -1.53 Million CAD | -175.04% |
| 2017 Q1 | -73 Thousand CAD | 93.29% |
| 2017 Q3 | 86 Thousand CAD | 109.85% |
| 2017 Q4 | -820 Thousand CAD | -1053.49% |
| 2017 Q2 | -873 Thousand CAD | -1095.89% |
| 2017 FY | - CAD | 11.41% |
| 2016 Q2 | -1.4 Million CAD | 31.96% |
| 2016 Q4 | -1.08 Million CAD | 40.87% |
| 2016 Q1 | -2.06 Million CAD | -113.26% |
| 2016 Q3 | -1.84 Million CAD | -31.15% |
| 2016 FY | - CAD | -134.5% |
| 2015 Q2 | -220 Thousand CAD | 88.0% |
| 2015 Q3 | -1.97 Million CAD | -799.09% |
| 2015 Q4 | 15.55 Million CAD | 886.3% |
| 2015 FY | - CAD | 330.76% |
| 2015 Q1 | -1.83 Million CAD | -18.72% |
| 2014 Q1 | 13.98 Million CAD | 103.37% |
| 2014 Q4 | -1.54 Million CAD | -4.39% |
| 2014 Q3 | -1.47 Million CAD | -6330.43% |
| 2014 Q2 | -23 Thousand CAD | -100.16% |
| 2014 FY | - CAD | -111.22% |
| 2013 FY | - CAD | 98.9% |
| 2013 Q3 | 13.86 Million CAD | 49.91% |
| 2013 Q4 | 6.87 Million CAD | -50.4% |
| 2013 Q2 | 9.24 Million CAD | -13.18% |
| 2013 Q1 | 10.65 Million CAD | 73.29% |
| 2012 Q3 | 1.21 Million CAD | -60.07% |
| 2012 Q4 | 6.14 Million CAD | 405.72% |
| 2012 FY | - CAD | 325.77% |
| 2012 Q2 | 3.04 Million CAD | 169.24% |
| 2012 Q1 | -4.39 Million CAD | 9.39% |
| 2011 Q1 | -4.21 Million CAD | -337.2% |
| 2011 Q4 | -4.85 Million CAD | -141.18% |
| 2011 Q2 | -5.1 Million CAD | -21.26% |
| 2011 Q3 | -2.01 Million CAD | 60.62% |
| 2011 FY | - CAD | -52.15% |
| 2010 FY | - CAD | -248.72% |
| 2010 Q3 | -741.23 Thousand CAD | 50.78% |
| 2010 Q2 | -1.5 Million CAD | -121.94% |
| 2010 Q1 | 6.86 Million CAD | 1191.21% |
| 2010 Q4 | -963.44 Thousand CAD | -29.98% |
| 2009 FY | - CAD | 210.26% |
| 2009 Q1 | -1.73 Million CAD | -66.98% |
| 2009 Q4 | -629 Thousand CAD | -20.35% |
| 2009 Q2 | -1.45 Million CAD | 16.08% |
| 2009 Q3 | -522.63 Thousand CAD | 64.06% |
| 2008 Q3 | -7907.00 CAD | -2.42% |
| 2008 Q1 | -18.41 Thousand CAD | -1024.74% |
| 2008 FY | - CAD | -6037.61% |
| 2008 Q4 | -1.03 Million CAD | -13024.5% |
| 2008 Q2 | -7720.00 CAD | 58.07% |
| 2007 Q3 | -31.09 Thousand CAD | -157.21% |
| 2007 Q4 | -1637.00 CAD | 94.74% |
| 2007 FY | - CAD | -709.73% |
| 2007 Q2 | -12.08 Thousand CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| MustGrow Biologics Corp. | -676.94 Thousand CAD | -245.673% |